ArticlePsychopharmacology2009

The sigma-1 antagonist BMY-14802 inhibits L-DOPA-induced abnormal involuntary movements by a WAY-100635-sensitive mechanism.

Melanie A Paquette et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.